World News: 13:00 GMT Wednesday 15th May 2019. [Vericel Corporation via Globe Newswire via SPi World News]
CAMBRIDGE, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, president and CEO, will present the latest company overview at the 2019 UBS Global Healthcare Conference in New York City on Wednesday, May 22, 2019 at 10:30am Eastern Time.
A live webcast of the presentation will be available on the Investor Relations section of the Vericel Corporation website at:
Epicel and MACI are registered trademarks of Vericel Corporation. © 2019 Vericel Corporation. NexoBrid is a registered trademark of MediWound Ltd. and is used under license to Vericel Corporation. All rights reserved.
Karen ChaseRusso Partners LLCKaren.firstname.lastname@example.org+1 646-942-5627 (office)+1 917-547-0434 (mobile)
Lee SternSolebury Troutlstern@troutgroup.com+1 646-378-2922
Globe Newswire: 13:00 GMT Wednesday 15th May 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.